ArticleOncoTargets and therapy2015

Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized controlled trials.

Xiaoping Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.